Epistatic Effects of Immunoglobulin GM and KM Allotypes on Outcome of Infection with Hepatitis C Virus

Journal of Virology

Volumn 78, Issue 9, 2004, Pages 4561-4565

  Pandey, Janardan P ^a   Astemborski, Jacquie ^b   Thomas, David L ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; HLA ANTIGEN; IMMUNOGLOBULIN ALLOTYPE; IMMUNOGLOBULIN KAPPA CHAIN; UNCLASSIFIED DRUG;

ADULT; ALLOTYPE; ARTICLE; CELLULAR IMMUNITY; CHROMOSOME 14; CHROMOSOME 2; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; EPISTASIS; FEMALE; GENETIC MARKER; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGLOBULIN GM; IMMUNOGLOBULIN KM; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SEROTYPING;

ADULT; CASE-CONTROL STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; IMMUNOGLOBULIN ALLOTYPES; IMMUNOGLOBULIN GM ALLOTYPES; MALE; MIDDLE AGED; PHENOTYPE; RNA, VIRAL;

EID: 13144271588     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.9.4561-4565.2004     Document Type: Article

References (47)

1. Biggar R. J., J. P. Pandey, W. Henle, F. K. Nkrumah, and P. H. Levine. 1984. Humoral immune response to Epstein-Barr virus antigens and immunoglobulin allotypes in African Burkitt lymphoma patients. Int. J. Cancer 33:577-580.
2. Black, F. L., G. Schiffman, and J. P. Pandey. 1995. HLA, Gm, and Km polymorphisms and immunity to infectious diseases in South Amerinds. Exp. Clin. Immunogenet. 12:206-216.
3. Ciofu, O., T. Pressler, J. P. Pandey, and N. Høiby. 1997. The influence of allotypes on the IgG subclass response to chromosomal β-1actamase P-lactamase of Pseudomonas aeruginosa in cystic fibrosis patients. Clin. Exp. Immunol. 108: 88-94.
4. Cooper, L. J. N., D. Robertson, R. Granzow, and N. S. Greenspan. 1994. Variable domain-identical antibodies exhibit IgG subclass-related differences in affinity and kinetic constants as determined by surface plasmon resonance. Mol. Immunol. 31:577-584.
5. Czerwinski M., D. Siemaszko, D. L. Siegel, and S. L. Spitalnik. 1998. Only selected light chains combine with a given heavy chain to confer specificity for a model glycopeptide antigen. J. Immunol. 160:4406-4417.
6. de Vries, R. R. P., P. Meera Khan, L. F. Bernini, E. van Loghem, and J. van Rood. 1979. Genetic control of survival in epidemics. J. Immunogenet. 6:271-287.
7. Dugoujon, J. M., and A. Cambon-Thomsen. 1995. Immunoglobulin allotypes (Gm and Km) and their interactions with HLA antigens in autoimmune diseases: a review. Autoimmunity 22:245-260.
8. Goldblatt, D., G. K. Scadding, V. J. Lund, A. M. Wade, M. W. Turner, and J. P. Pandey. 1994. Association of Gm allotypes with the antibody response to the outer membrane proteins of a common upper respiratory tract organism, Moraxella catarrhalis. J. Immunol. 153:5316-5320.
9. Granoff, D. M., B. K. Suarez, J. P. Pandey, and P. G. Shackelford. 1988. Genes associated with the G2m (23) immunoglobulin allotype regulate the IgG subclass responses to Haemophilus influenzae type b polysaccharide vaccine. J. Infect. Dis. 157:1142-1149.
10. Granoff, D. M., E. Boies, J. Squires, J. P. Pandey, B. Suarez, J. Oldfather, and G. E. Rodey. 1984. Interactive effect of genes associated with immunoglobulin allotypes and HLA specificities on susceptibility to Haemophilus influenzae disease. J. Immunogenet. 11:181-188.
11. Granoff, D. M., J. P. Pandey, E. Boies, J. Squires, R. S. Munson, Jr., and B. Suarez. 1984. Response to immunization with Haemophilus influenzae type b polysaccharide-pertussis vaccine and risk of Haemophilus meningitis in children with the Km(I) immunoglobulin allotype. J. Clin. Investig. 74:1708-1714.
12. Herrera, P. J., M. Arcos-Burgos, C. Y. Valenzuela, and J. P. Pandey. 1996. GM and KM allotypes and typhoid fever. Exp. Clin. Immunogenet. 13:121-125.
13. Kacprzak-Bergman, I., and J. Halasa. 1994. Gm and Km phenotype frequencies in children with chronic active hepatitis (CAH) B virus infection. Eur. J. Immunogenet. 21:373-376.
14. Kanto, T., N. Hayashi, T. Takehara, K. Katayama, A. Ito, K. Mochizuki, N. Kuzushita, T. Tatsumi, Y. Sasaki, A. Kasahara, and M. Hori. 1998. Cross-linking of Fc(gamma)-receptor on monocytes inhibits hepatitis C virus-specific cytotoxic T-lymphocyte induction in vitro. Immunology 94:461-468.
15. Lal, R. B., C. Buckner, R. F. Khabbaz, J. E. Kaplan, G. Reyes, K. Hadlock, J. Lipka, S. K. H. Foung, L. Chan, and J. E. Coligan. 1993. Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I. Clin. Immunol. Immunopathol. 67:40-49.
16. Legrand, L., L. Rivat-Perran, C. Huttin, and J. Dausset. 1982. HLA-and Gm-linked genes affecting the degradation rate of antigens (sheep red blood cells) endocytized by macrophages. Hum. Immunol. 4:1-13.
17. McLean, G. R., M. Torres, N. Elguezabal, A. Nakouzi, and A. Casadevall. 2002. Isotype can affect the fine specificity of an antibody for a polysaccharide antigen. J. Immunol. 169:1379-1386.
18. Morahan, G., C. Berek, and J. F. A. P. Miller. 1983. An idiotypic determinant formed by both immunoglobulin constant and variable regions. Nature 301:720-722.
19. Morell, A., F. Skvaril, A. G. Steinberg, E. Van Loghem, and W. D. Terry. 1972. Correlations between the concentrations of the four sub-classes of IgG and Gm allotypes in normal human sera. J. Immunol. 108:195-206.
20. Moxley, G., and R. S. Gibbs. 1992. Polymerase chain reaction-based genotyping for allotypic markers of immunoglobulin kappa shows allelic association of Km with kappa variable segment. Genomics 13:104-108.
21. Pandey, J. P. 2001. Immunoglobulin GM and KM allotypes and vaccine immunity. Vaccine 19:613-617.
22. Pandey, J. P., and M. A. H. French. 1996. GM phenotypes influence the concentrations of the four subclasses of immunoglobulin G in normal human serum. Hum. Immunol. 51:99-102.
23. Pandey, J. P., and M. J. Blaser. 1986. Heterozygosity at the Km locus associated with humoral immunity to Campylobacter jejuni. Exp. Clin. Immunogenet. 3:49-53.
24. Pandey, J. P., C. J. Baker, D. L. Kasper, and H. H. Fudenberg. 1984. Two unlinked genetic loci interact to control the human immune response to type III group B streptococcal antigen. J. Immunogenet. 11:159-163.
25. Pandey, J. P., F. Ambrosch, H. H. Fudenberg, G. Stanek, and G. Wiedermann. 1982. Immunoglobulin allotypes and immune response to meningococcal polysaccharides A and C. J. Immunogenet. 9:25-29.
26. Pandey, J. P., H. H. Fudenberg, G. Virella, C. U. Kyong, C. B. Loadholt, R. M. Galbraith, E. C. Gotschlich, and J. C. Parke, Jr. 1979. Association between immunoglobulin allotypes and immune responses to Haemophilus influenzae and meningococcus polysaccharides. Lancet i:190-192.
27. Pandey, J. P., J. C. Gunsolley, J. G. Tew, and H. A. Schenkein. 1996. Gm allotypes and IgG subclass concentrations in blacks. Exp. Clin. Immunogenet. 13:126-130.
28. Pandey, J. P., L. H. Elson, S. E. Sutherland, R. H. Guderian, E. Araujo, and T. B. Nutman. 1995. Immunoglobulin K chain allotypes (KM) in onchocerciasis. J. Clin. Investig. 96:2732-2734.
29. Pandey, J. P., W. D. Zollinger, H. H. Fudenberg, and C. B. Loadholt. 1981. Immunoglobulin allotypes and immune response to meningococcal group B polysaccharide. J. Clin. Investig. 68:1378-1380.
30. Pressler, T., J. P. Pandey, F. Espersen, S. S. Pedersen, A. Fomsgaard, C. Koch, and N. Hoiby. 1992. Immunoglobulin allotypes and IgG subclass antibody response to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients. Clin. Exp. Immunol. 90:209-214.
31. Primi, D., A. M. Drapier, and P. A. Cazenave. 1987. Highly preferential VH-VL pairing in normal B cells results in antigen-independent selection of the available repertoire. J. Immunol. 138:1607-1612.
32. H1 constant region domain modulate antigen binding affinity of antibodies? J. Clin. Investig. 98:2235-2243.
33. Rodriguez-Barradas, M. C., J. E. Groover, C. E. Lacke, D. W. Gump, C. J. Lahart, J. P. Pandey, and D. M. Musher. 1996. IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjects: persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response. J. Infect. Dis. 173:1347-1353.
34. Sarvas, H., N. Rautonen, and O. Makela. 1991. Allotype-associated differences in concentrations of human IgG subclasses. J. Clin. Immunol. 11:39-45.
35. Schmidt, W., B. Konigstedt, B. Zipprich, E. Scheibe, and R. Nilius. 1987. Immunoglobulin allotypes and immunoreactivity in chronic liver disease. Hepato-Gastroenterology 34:206-211.
36. Shows, T. B., P. J. McAlpine, C. Boucheix, F. S. Collins, P. M. Conneally, J. Frezal, H. Gershowitz, P. N. Goodfellow, J. G. Hall, P. Issitt, C. A. Jones, B. B. Knowles, M. Lewis, V. A. McKusick, M. Meisler, N. E. Morton, P. Rubinstein, M. S. Schanfield, R. D. Schmickel, M. H. Skolnick, M. A. Spence, G. R. Sutherland, M. Traver, N. van Cong, and H. F. Willard. 1987. Guidelines for human gene nomenclature. An international system for human gene nomenclature (ISGN, 1987). Cytogenet. Cell Genet. 46:11-28.
37. Skvaril, F. 1986. IgG subclasses in viral infections. Monogr. Allergy 19:134-143.
38. Steinberg, A. G., and C. E. Cook. 1981. The distribution of human immunoglobulin allotypes. Oxford University Press, New York, N.Y.
39. Sundquist, V. A., A. Linde, R. Kurth, A. Werner, E. B. Helm, M. Popovic, R. C. Gallo, and B. Wahren. 1986. Restricted IgG subclass responses to HTLV-III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome. J. Infect. Dis. 153:970-973.
40. Thio, C. L., D. L. Thomas, J. J. Goedert, D. Vlahov, K. E. Nelson, M. W. Hilgartner, S. J. O'Brien, P. Karacki, D. Marti, J. Astemborski, and M. Carrington. 2001. Racial differences in HLA class II associations with hepatitis C virus outcomes. J. Infect. Dis. 184:16-21.
41. Thio, C. L., X. Gao, J. J. Goedert, D. Vlahov, K. E. Nelson, M. W. Hilgartner, S. J. O'Brien, P. Karacki, J. Astemborski, M. Carrington, and D. L. Thomas. 2002. HLA-Cw*04 and hepatitis C virus persistence. J. Virol. 76:4792-4797.
42. Thomas, D. L., J. Astemborski, R. M. Rai, F. A. Anania, M. Schaeffer, N. Galai, K. Nolt, K. E. Nelson, S. A. Strathdee, L. Johnson, O. Laeyendecker, J. Boitnott, L. E. Wilson, and D. Vlahov. 2000. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 284:450-456.
43. Thursz, M., R. Yallop, R. Goldin, C. Trepo, H. C. Thomas, et al. 1999. Influence of MHC class II genotype on outcome of infection with hepatitis C virus. Lancet 354:2119-2124.
44. Vlahov, D., J. C. Anthony, A. Muñoz, J. Margolik, D. D. Celentano, L. Solomon, and B. F. Polk. 1991. The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods. J. Drug Issues 21:759-776.
45. Vyas, G. N., H. H. Fudenberg, H. M. Pretty, and E. R. Gold. 1968. A new rapid method for genetic typing of human immunoglobulins. J. Immunol. 100:274-279.
46. Wachsmuth, R. R., J. P. Pandey, J. A. Fedrick, Y. Nishimura, and T. Sasazuki. 1987. Interactive effect of Gm and Km allotypes on cellular immune responses to streptococcal cell wall antigen. Exp. Clin. Immunogenet. 4:163-166.
47. World Health Organization. 1997. Hepatitis C: global prevalence. Wkly. Epidemiol. Rec. 72:341-348.